The cause of invasive cervical cancer could be multifactorial.

[1]  M. Kazatchkine,et al.  Early regression of cervical lesions in HIV‐seropositive women receiving highly active antiretroviral therapy , 1998, AIDS.

[2]  M. Chiasson,et al.  Human Papillomavirus Infection in Women Infected with the Human Immunodeficiency Virus , 1997 .

[3]  J. Linder A Decade Has Passed , 1997 .

[4]  E. Negri,et al.  Case-control study of oestrogen replacement therapy and risk of cervical cancer , 1997, BMJ.

[5]  J. Zhang,et al.  Vaginal douching and adverse health effects: a meta-analysis. , 1997, American journal of public health.

[6]  S. Waggoner,et al.  Identification of Tobacco- Specific Carcinogen in the Cervical Mucus of Smokers and Nonsmokers , 1997 .

[7]  D Hoffmann,et al.  The changing cigarette, 1950-1995. , 1997, Journal of toxicology and environmental health.

[8]  S. Schwartz,et al.  The relationship of human papillomavirus-related cervical tumors to cigarette smoking, oral contraceptive use, and prior herpes simplex virus type 2 infection. , 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[9]  R. Burk,et al.  Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. , 1995, Journal of the National Cancer Institute.

[10]  V. Moreno,et al.  Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide Perspective , 1995 .

[11]  S. Garland,et al.  A Cohort Study Comparing the Detection of HPV DNA from Women Who Stop and Continue to Smoke , 1995, The Australian & New Zealand journal of obstetrics & gynaecology.

[12]  J. Kaldor,et al.  Risk factors for cervical cancer in Colombia and Spain , 1992, International journal of cancer.

[13]  K. Holmes,et al.  A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection , 1992, The New England journal of medicine.

[14]  Moyses Szklo,et al.  Herpes simplex virus type 2: A possible interaction with human papillomavirus types 16/18 in the development of invasive cervical cancer , 1991, International journal of cancer.

[15]  W. Winkelstein,et al.  Smoking and cervical cancer--current status: a review. , 1990, American journal of epidemiology.

[16]  T. French,et al.  Dietary Vitamins A, C, and E and Selenium as Risk Factors for Cervical Cancer , 1990, Epidemiology.

[17]  T. French,et al.  Sexual activity, contraception, genital infections, and cervical cancer: support for a sexually transmitted disease hypothesis. , 1989, American journal of epidemiology.

[18]  M. Chacko,et al.  Vaginal douching in teenagers attending a family planning clinic. , 1989, Journal of adolescent health care : official publication of the Society for Adolescent Medicine.

[19]  P. Layde Smoking and cervical cancer: cause or coincidence? , 1989, JAMA.

[20]  T. French,et al.  Cigarette smoking and exposure to passive smoke are risk factors for cervical cancer. , 1989, JAMA.

[21]  D. Celentano,et al.  The role of contraceptive use in cervical cancer: the Maryland Cervical Cancer Case-Control Study. , 1987, American journal of epidemiology.

[22]  J. Cuzick,et al.  progressive Potential of Mild Cervical Atypia : Prospective Cytological, Colposcopic, and Virologic Study , 1987 .

[23]  J. Fraumeni,et al.  Epidemiology of cervical cancer by cell type. , 1987, Cancer research.

[24]  B. Henderson,et al.  Risk factors for invasive cervical cancer among Latinas and non-Latinas in Los Angeles County. , 1986, Journal of the National Cancer Institute.

[25]  D. Savitz,et al.  Long‐term use of oral contraceptives and risk of invasive cervical cancer , 1986, International journal of cancer.

[26]  J. Cuzick,et al.  PROGRESSIVE POTENTIAL OF MILD CERVICAL ATYPIA: PROSPECTIVE CYTOLOGICAL, COLPOSCOPIC, AND VIROLOGICAL STUDY , 1986, The Lancet.

[27]  R. Deitch Commentary from Westminster , 1984, The Lancet.

[28]  J. Best,et al.  Class‐specific antibodies (Igg and Iga) to membrane antigens of herpes simplex type‐2 infected cells in patients with cervical dysplasia and neoplasia , 1981, International journal of cancer.

[29]  J. Frank,et al.  The incidence of cervical cancer and duration of oral contraceptive use. , 1977, American journal of epidemiology.

[30]  M. Modan,et al.  Antibodies to Herpes simplex virus in Jewish women with cervical cancer and in healthy Jewish women of Israel. , 1975, Journal of the National Cancer Institute.

[31]  B. Roizman,et al.  A DNA fragment of Herpes simplex 2 and its transcription in human cervical cancer tissue. , 1972, Proceedings of the National Academy of Sciences of the United States of America.

[32]  I. D. Rotkin Epidemiology of cancer of the cervix. 3. Sexual characteristics of a cervical cancer population. , 1967, American journal of public health and the nation's health.

[33]  C. Southam,et al.  JOINT ACTION OF HERPES SIMPLEX VIRUS AND 3-METHYLCHOLANTHRENE IN PRODUCTION OF PAPILLOMAS IN MICE. , 1965, Journal of the National Cancer Institute.

[34]  H. L. Lombard Epidemiology of Cancer of the Cervix , 1956 .

[35]  P. Rous,et al.  JOINT ACTION OF A CHEMICAL CARCINOGEN AND A NEOPLASTIC VIRUS TO INDUCE CANCER IN RABBITS , 1951, The Journal of experimental medicine.

[36]  P. Rous,et al.  THE CARCINOGENIC EFFECT OF A PAPILLOMA VIRUS ON THE TARRED SKIN OF RABBITS : I. DESCRIPTION OF THE PHENOMENON. , 1938, The Journal of experimental medicine.

[37]  R. Herrero Epidemiology of cervical cancer. , 1996, Journal of the National Cancer Institute. Monographs.

[38]  F. Buonaguro,et al.  Human immunodeficiency virus type 1 tat gene enhances human papillomavirus early gene expression. , 1993, Intervirology.

[39]  V. Devita,et al.  Cancer : Principles and Practice of Oncology , 1982 .

[40]  H. L. Lombard,et al.  Epidemiological aspects of cancer of the cervix. II. Hereditary and environmental factors , 1950, Cancer.